Reach Us +44-1647-403003
Phthalates Acting As A Tumor Promoter Through Nongenomic AhR/ HDAC6/c-Myc Signaling In ER Negative Human Breast Cancer | 5259
ISSN: 2157-7013

Journal of Cell Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Phthalates acting as a tumor promoter through nongenomic AhR/ HDAC6/c-Myc signaling in ER negative human breast cancer

International Conference & Exhibition on Cell Science & Stem Cell Research

Tsung-Hua Hsieh1 and Eing-Mei Tsai

Posters: J Cell Sci Ther

DOI: 10.4172/2157-7013.S1.15

Th e environmental hormone phthalates play important roles in regulating the expression of genes involved in cell proliferation, drug resistance, and breast cancer risk. However, their precise mechanism in tumor progression in breast cancer remains unclear. To elucidate the eff ect of phthalates on tumor progression, we evaluated the consequences of phthalate treatment on tumor growth and motility in breast cancer cells. We found that phthalates increased ER negative breast cancer cells growth, migration, invasion, colony formation, and stimulated tumor growth in nude mice. In addition, phthalates are mediators of non-genomic actions of AhR at the plasma membrane and increased HDAC6 expression in MDA-MB-231 cells. Phthalate treatment induced non-genomic signals of AhR through cyclic AMP/PKA activation at Ser133 of CREB1 and permitted CREB1 binding to the HDAC6 promoter. Furthermore, a small interfering RNA targeting HDAC6 mRNA reduced β-catenin translocation to the nucleus and decreased c-Myc expression, resulting in the inhibition of proliferation and motility. Th us, the results identify a new pathway of AhR/HDAC6/c-Myc-mediated tumor-progression activity via exposure to phthalates in the ER negative breast cancer
Relevant Topics